Unlisted Shares / Arch Pharmalabs Limited Unlisted Shares
Arch Pharmalabs Limited Unlisted Shares

Arch Pharmalabs Limited Unlisted Shares Unlisted Share Price

As of , the indicative unlisted share price of Arch Pharmalabs Limited Unlisted Shares is ₹85 per share. This is an over-the-counter reference price, not a stock-exchange quote.

As of , Arch Pharmalabs Limited Unlisted Shares is not listed on any Indian stock exchange (NSE or BSE) — its shares trade in the unlisted, over-the-counter (pre-IPO) market.

  • Sector: Pharmaceuticals
  • Status: Unlisted
  • Indicative price: ₹85 per share (as of 16 July 2026)
  • Minimum lot: 120 shares
  • Minimum investment:10,200
Industry: PharmaceuticalsIncorporated: 2001Unlisted
Daily price
₹85
₹0 (+0.00%)· 1W
As of 16 Jul 2026
8 Jul16 Jul
Indicative. Past performance is not indicative of future results.
At a glance
Price / unit₹85
Market cap₹1,330 Cr
Min. investment₹10,200
Lot size120
P/E ratio10.9
P/B ratio1.57
Key metrics
Price / unit
₹85
Market cap
₹1,330 Cr
Min. investment
₹10,200
Lot size
120
P/E ratio
10.9
P/B ratio
1.57
ROE
14.57%
Book value
₹54.16
Face value
₹10
EPS
7.8
Debt / equity
1.01
Company information
CIN
U24231MH1993PLC150891
ISIN
INE182F01017
PAN
AACCM0306Q
Depository
NSDL & CDSL
Incorporated
2001
Outstanding shares
156480000
₹ in lakhFY23
Revenue1,341
Profit after tax122
EPS (₹)8
Revenue (₹ in lakh)
FY23
1,341
₹ in lakhFY23
Share capital157
Reserves & surplus681
Investments13
Fixed assets820
Trade receivables698
Trade payables266
₹ in lakhFY23
Operating (CFO)42
Investing (CFI)-1
Financing (CFF)-41
Net cash generated0
Net margin9.1%
Operating margin13.4%

What is Arch Pharmalabs Limited Unlisted Shares?

Arch Pharmalabs Limited Unlisted Shares is an unlisted Pharmaceuticals company whose shares trade in India's over-the-counter (pre-IPO) market and settle in demat form (NSDL/CDSL).

Arch Pharmalabs Limited is a pharmaceutical manufacturing company focused on producing Active Pharmaceutical Ingredients (APIs) and intermediates, which are key raw materials used in making medicines. The company also offers contract development and manufacturing services (commonly known as CRAMS), supporting global pharma companies across the drug lifecycle—from early-stage development to commercial production. Established in 1993 and headquartered in Mumbai, the company operates multiple manufacturing facilities in India and caters to both domestic and international markets, including regulated regions like the US and Europe.

Arch Pharmalabs Limited Unlisted Shares
Price per unit₹85
Minimum units120
Units
120
Indicative amount10,200
Request details
Leave your details and we'll get in touch.
Talk to our team
Settles into your own demat (NSDL/CDSL)
Gayatri Financial Synergy — since 2002
We reply within 3 business days
Reviewed by Kanishk Dev Bangia · NISM-202300182946. Indicative pricing, subject to availability, documentation and final settlement. Information only — not investment advice.

Explore more unlisted shares

Other companies in our curated selection.

Arch Pharmalabs Limited Unlisted Shares unlisted shares

Frequently asked questions

No. As of 16 July 2026, Arch Pharmalabs Limited Unlisted Shares is an unlisted company whose shares trade over-the-counter; it would list only if and when it completes an IPO.

The minimum lot is 120 share(s); at the indicative price of about ₹85, that is approximately ₹10,200. Indicative reference, not a quote.

As of 16 July 2026, the indicative unlisted share price of Arch Pharmalabs Limited Unlisted Shares is ₹85 per share. This is an over-the-counter reference price, not a stock-exchange quote.

The ISIN of Arch Pharmalabs Limited Unlisted Shares is INE182F01017. An ISIN is the unique 12-character code that identifies a company's shares in the depository system; this one is verified against NSDL (the National Numbering Agency). You need it to hold or transfer these unlisted shares in your NSDL or CDSL demat account.

Yes. Trading in unlisted shares is legal in India and takes place in the over-the-counter market through authorised platforms and intermediaries.

Unlisted companies are not directly regulated the same way as listed ones, but transfers and the eventual listing process fall under SEBI and applicable company-law frameworks.

Per current SEBI rules, unlisted shares acquired before listing are typically subject to a lock-in period after the company lists. Specifics are confirmed at the time of the deal.

No. Unlisted shares carry higher risk and lower liquidity than listed shares. Returns depend on company performance, market conditions and future listing outcomes.

They can. If the company declares a dividend, unlisted shareholders are eligible like any other shareholder. Many unlisted firms reinvest profits, so dividends are not guaranteed.

After listing, unlisted shares convert into regular listed shares in your demat account and can be traded on the exchange, usually once any applicable SEBI lock-in period ends.

Unlisted shares are less liquid than listed shares. You can sell when a buyer is available through an off-market transfer; there is no continuous exchange market, so exits can take longer.

Unlisted shares carry higher risk and lower liquidity than listed shares, with fewer disclosures and no live market price. This is general information, not investment advice — assess suitability before investing.

An unlisted share price is an indicative, over-the-counter reference set by demand and supply in private deals between buyers and sellers. There is no live exchange quote, so prices can vary across dealers and over time.

Yes. Unlisted shares are delivered in dematerialised form, so you need an active demat account (NSDL or CDSL). No special account type is required — a regular demat account works.

Unlisted shares are sold through an off-market transfer to a buyer via a registered intermediary, settling from your demat account with a contract note. Liquidity depends on buyer availability, so exits can take longer than listed shares.

Want help evaluating Arch Pharmalabs Limited Unlisted Shares?

Our research team can walk you through the disclosures, risks and process — no obligation.

Book a call
Compare

Arch Pharmalabs Limited Unlisted Shares vs similar unlisted Pharmaceuticals shares

Indicative over-the-counter prices, as of 16 July 2026. Information only — not a recommendation or ranking.

CompanyIndicative priceP/ELotMin. investment
Arch Pharmalabs Limited Unlisted Shares This page₹8510.90120₹10,200
Martin and Harris Laboratories Limited₹8954.7115₹13,425
East India Pharmaceutical Works Limited₹7926.33130₹10,270
Gynofem Healthcare and Pharmaceutical₹64160₹10,240
Arch Pharmalabs Limited Unlisted Shares vs Martin and Harris Laboratories LimitedArch Pharmalabs Limited Unlisted Shares vs East India Pharmaceutical Works LimitedArch Pharmalabs Limited Unlisted Shares vs Gynofem Healthcare and Pharmaceutical
Ask our AI